iShares S&P 500 Health Care Sector UCITS ETF (ETR:QDVG)
Germany
· Delayed Price · Currency is EUR | Assets | 2.31B |
| Expense Ratio | 0.15% |
| PE Ratio | 24.48 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -4.93% |
| Volume | 16,675 |
| Open | 9.70 |
| Previous Close | 9.67 |
| Day's Range | 9.64 - 9.75 |
| 52-Week Low | 9.12 |
| 52-Week High | 11.39 |
| Beta | 0.65 |
| Holdings | 68 |
| Inception Date | Nov 20, 2015 |
About QDVG
iShares S&P 500 Health Care Sector UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the health care sector, which include companies involved in the health care equipment and supplies or provide health care related services, including distributors of health care products, providers of basic health-care services, owners and operators of health care facilities and organizations, and research, development, production, and marketing of pharmaceuticals and biotechnology products. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the S&P 500 Health Care Index, by investing in the stocks of companies as per their weightings in the index. iShares S&P 500 Health Care Sector UCITS ETF was formed on August 22, 2011 and is domiciled in Ireland.
Performance
QDVG had a total return of -4.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.42%.
Top 10 Holdings
56.76% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 13.82% |
| UnitedHealth Group Incorporated | UNH | 7.64% |
| Johnson & Johnson | JNJ | 7.38% |
| AbbVie Inc. | ABBV | 6.51% |
| Abbott Laboratories | ABT | 4.43% |
| Merck & Co., Inc. | MRK | 4.15% |
| Intuitive Surgical, Inc. | ISRG | 3.64% |
| Thermo Fisher Scientific Inc. | TMO | 3.22% |
| Amgen Inc. | AMGN | 2.99% |
| Boston Scientific Corporation | BSX | 2.98% |